Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1996
Pharmacological considerations in the modulation of multidrug resistance
G A Fisher, B L Lum, J Hausdorff, et al.
Pharmacotherapy
|
March 1, 1993
Molecular targets in oncology: implications of the multidrug resistance gene
B L Lum, M P Gosland, S Kaubisch, et al.
Therapeutic Drug Monitoring
|
June 1, 1995
Comparison of three methods for cyclosporine area under the curve monitoring calculations
G M Dalere, B L Lum, G F Cooney, et al.
The Journal of Urology
|
July 1, 1991
Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion
S Kaubisch, B L Lum, J Reese, et al.
Drug Intelligence & Clinical Pharmacy
|
February 1, 1987
Evaluation of three manual drug information retrieval systems for investigational antineoplastic drugs
A Al Hefzi, P N Catania, M A Mergener, et al.
Transplantation Proceedings
|
August 1, 1996
Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients
G F Cooney, B L Lum, J A Meligeni, et al.
Cancer
|
August 15, 1984
Tamoxifen in advanced prostatic carcinoma. A dose escalation study
F M Torti, B L Lum, R Lo, et al.
Cancer Chemotherapy and Pharmacology
|
February 7, 2001
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance
B L Lum, S Kaubisch, G A Fisher, et al.
Therapeutic Drug Monitoring
|
June 1, 1997
Comparison and validation of limited sampling equations for cyclosporine area-under-the-curve monitoring calculations in pediatric renal transplant recipients
J E Charlebois, B L Lum, G F Cooney, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology Group
M W DeGregorio, B L Lum, W M Holleran, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1996
Pharmacological considerations in the modulation of multidrug resistance
G A Fisher, B L Lum, J Hausdorff, et al.
Pharmacotherapy
|
March 1, 1993
Molecular targets in oncology: implications of the multidrug resistance gene
B L Lum, M P Gosland, S Kaubisch, et al.
Therapeutic Drug Monitoring
|
June 1, 1995
Comparison of three methods for cyclosporine area under the curve monitoring calculations
G M Dalere, B L Lum, G F Cooney, et al.
The Journal of Urology
|
July 1, 1991
Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion
S Kaubisch, B L Lum, J Reese, et al.
Drug Intelligence & Clinical Pharmacy
|
February 1, 1987
Evaluation of three manual drug information retrieval systems for investigational antineoplastic drugs
A Al Hefzi, P N Catania, M A Mergener, et al.
Transplantation Proceedings
|
August 1, 1996
Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients
G F Cooney, B L Lum, J A Meligeni, et al.
Cancer
|
August 15, 1984
Tamoxifen in advanced prostatic carcinoma. A dose escalation study
F M Torti, B L Lum, R Lo, et al.
Cancer Chemotherapy and Pharmacology
|
February 7, 2001
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance
B L Lum, S Kaubisch, G A Fisher, et al.
Therapeutic Drug Monitoring
|
June 1, 1997
Comparison and validation of limited sampling equations for cyclosporine area-under-the-curve monitoring calculations in pediatric renal transplant recipients
J E Charlebois, B L Lum, G F Cooney, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology Group
M W DeGregorio, B L Lum, W M Holleran, et al.
Page
of 6